LEADER 01483nam  2200493   450 
001 9910703497003321
005 20170814165047.0
010   $a1-4649-1279-3
035   $a(CKB)2670000000183015
035   $a(EBL)3400998
035   $a(SSID)ssj0001429338
035   $a(PQKBManifestationID)11759104
035   $a(PQKBTitleCode)TC0001429338
035   $a(PQKBWorkID)11464237
035   $a(PQKB)11442514
035   $a(MiAaPQ)EBC3400998
035   $a(OCoLC)882093856
035   $a(EXLCZ)992670000000183015
100   $a20150415h20122012  uy             0
101 0 $aeng
135   $aur|n|---|||||
181   $ctxt
182   $cc
183   $acr
200 00$aMyoclonus $enew insights for the healthcare professional ScholarlyPaper /$fQ. Ashton Acton, general editor
205   $a2011th ed.
210  1$aAtlanta, Georgia :$cScholarlyEditions,$d2012.
210  4$dİ2012
215   $a1 online resource (20 p.)
225 1 $aNIH publication ;$vno. 12-4793
300   $aIncludes index.
327   $a""Cover""; ""Main""; ""Index""
606   $aMyoclonus$xResearch
615  0$aMyoclonus$xResearch.
676   $a616.84
702   $aActon$b Q. Ashton
712 02$aNational Institute of Neurological Disorders and Stroke (U.S.).$bOffice of Communications and Public Liaison,
801  0$bMiAaPQ
801  1$bMiAaPQ
801  2$bMiAaPQ
906   $aBOOK
912   $a9910703497003321
996   $aMyoclonus$93139605
997   $aUNINA